Good to see that a few here are still holding the
Post# of 15624
(Total Views: 401)
Posted On: 07/10/2017 4:58:33 PM
Good to see that a few here are still holding the fort. Speaking of which has anyone heard from FELLER?
I just sent an email to Amir asking to comment on why it seems that every time there is an 8-k or press release the market views it negatively. For example filing the psoriasis patent applications in both the US and in Europe seems to have been the appropriate thing to do, but yet the naysayers just see it as another attempt by the company to buy more time and extend the process.
I also asked Amir to clarify what they mean when they say that the psoriasis cream is "market ready". The company has basically been implying that its introduction to the market is imminent. But if they just filed the patent applications would they not be compromising their IP by licensing and starting to manufacture the cream?
Upon re-reading the June 27 patent application with the USPTO I reflected on the wording "topical cream is ready for marketing and commercial exploitation". My understanding is that "commercial exploitation" doesn't necessarily have to mean sales of the product. This is consistent with the legal definition of Commercial Exploitation that states: It includes all activities used to benefit commercially from one's property. Examples include making property, selling it, offering it for sale, or licensing its appropriation or use. Could it be that this has indeed been the company's intention all along and it's what they mean when they use the term "market ready"?
Even though it's been a hard day to remain objective, if anyone has any thoughts and comments, it's appreciated. Thx!
I just sent an email to Amir asking to comment on why it seems that every time there is an 8-k or press release the market views it negatively. For example filing the psoriasis patent applications in both the US and in Europe seems to have been the appropriate thing to do, but yet the naysayers just see it as another attempt by the company to buy more time and extend the process.
I also asked Amir to clarify what they mean when they say that the psoriasis cream is "market ready". The company has basically been implying that its introduction to the market is imminent. But if they just filed the patent applications would they not be compromising their IP by licensing and starting to manufacture the cream?
Upon re-reading the June 27 patent application with the USPTO I reflected on the wording "topical cream is ready for marketing and commercial exploitation". My understanding is that "commercial exploitation" doesn't necessarily have to mean sales of the product. This is consistent with the legal definition of Commercial Exploitation that states: It includes all activities used to benefit commercially from one's property. Examples include making property, selling it, offering it for sale, or licensing its appropriation or use. Could it be that this has indeed been the company's intention all along and it's what they mean when they use the term "market ready"?
Even though it's been a hard day to remain objective, if anyone has any thoughts and comments, it's appreciated. Thx!
(4)
(0)